Newsletter | November 23, 2022

11.23.22 -- Challenges & Solutions In Cell & Gene Therapy Manufacturing

From The Editor
Industry Insights
The 3 Cs You Should Expect From Your Pharma Service Provider

Learn what indicates whether a service provider has the capabilities desired by a drug sponsor to fulfill a company’s long-term goals and is committed to their success.

Manufacturing Challenges And Solutions In Cell And Gene Therapy Manufacturing

Discover the three major challenges cell and gene therapy manufacturers are facing today and experienced insights on how to overcome them.

CDMO Timebombs: Five Ways The Wrong Partner Can Lead To Trouble

A manufacturing partner that can't manage the complexities of your biologic can cause problems large and small, putting your next level of funding, or even the future of your company, in jeopardy.

Are Real-Time Gene Therapy Test Results Possible?

Along with the complexities of vaccine and viral-based gene therapy process development comes the need for analytical techniques that can help assess quality parameters, especially in real time.

Outsourced Pharma Live

Available On Demand! Throughout the year, chief editor Louis Garguilo brings together industry experts to discuss some of the biggest challenges being faced by both sponsors and CDMOs. Our archived videos can be accessed at any time by registered site users.